FDA-Approved Laser Treatment Vows To Tackle Hair Loss In Months 

Israeli company Lumenis, which creates energy-based medical devices, has unveiled its new FDA-approved laser system FoLix to combat hair loss. 

The company says it is the first and only fractional laser treatment for safe, effective and natural hair loss treatment for women and men in the US. 

FoLix uses laser pulses to stimulate the hair follicles, and studies showed that this has a positive impact on hair growth, with visible increase in hair count and improvement in scalp hair appearance. 

Lumenis says its treatment does not include chemicals, needles or invasive procedures, and offers results within four to six monthly sessions. 

“Fractional lasers have been shown to have remarkable effects on the skin and now, finally, Lumenis has been able to harness that power and bring an innovative solution for hair stimulation,” said Dr. Marc Avram, a renowned hair transplant specialist and Clinical Professor of Dermatology at Weill Cornell Medical College (WCMC).

“At Lumenis, we’re committed to transforming lives through science and innovation. FoLix is about more than just hair; it’s about having the self-confidence to live life to the fullest,” said Lumenis CEO Tzipi Ozer-Armon. 

“We are eager to collaborate with providers across the US to extend the influence and accessibility of this groundbreaking solution.”

The company is based in Yokne’am Illit, with offices all over the world, including Australia, China, India, Italy, South Korea and the UK.